Senores Pharmaceuticals Limited (BOM:544319)
1,385.90
-13.65 (-0.98%)
At close: Jul 20, 2026
Senores Pharmaceuticals Market Cap
Senores Pharmaceuticals has a market cap or net worth of 64.66 billion as of July 21, 2026. Its market cap has increased by 124.87% in one year.
Market Cap
64.66B
Enterprise Value
66.79B
Revenue
6.33B
Ranking
n/a
PE Ratio
55.56
Stock Price
1,385.90
ChartMarket Cap Chart
Since December 30, 2024, Senores Pharmaceuticals's market cap has increased from 25.65B to 64.66B, an increase of 152.04%. That is a compound annual growth rate of 81.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 63.78B | 68.45% |
| Dec 31, 2025 | 37.87B | 44.60% |
| Dec 31, 2024 | 26.19B | 2.07% |
| Dec 30, 2024 | 25.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORONA Remedies | 127.84B |
| Viyash Scientific | 115.53B |
| Procter & Gamble Health | 113.67B |
| Sanofi India | 78.16B |
| FDC Limited | 68.13B |
| Bliss GVS Pharma | 51.90B |
| Novartis India | 41.30B |
| Unichem Laboratories | 41.25B |